FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...
health.economictimes.indiatimes12h
Webinar on Living with IBD and choosing the right treatment
Inflammatory Bowel Disease (IBD) is a term for chronic inflammatory conditions affecting the digestive tract, primarily Crohn ...
GlobalData on MSN7h
Palisade Bio begins MAD cohorts of Phase Ia/b ulcerative colitis therapy trial
Palisade Bio has begun the multiple ascending dose (MAD) cohorts of its ongoing Phase Ia/b trial of PALI-2108 for ulcerative ...
Onlymyhealth3d
How Pregnant Women Can Manage Ulcerative Colitis: Are Medications Safe To Take?
Ulcerative colitis during pregnancy is manageable However timely detection and proper treatment are crucial to ensure a ...
Palisade Bio Completes All Five SAD Cohorts and Advances to MAD Cohorts of Phase 1a/b Study of PALI-2108 for Treatment of Ulcerative Colitis
Company on track to report topline data in first half of 2025Positive preliminary data from all five single ascending dose (SAD) cohorts ranging ...
Medpage Today on MSN7h
Children With IBD Showed Impaired Growth Before Diagnosis
Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index ...
Trethera Announces Inflammatory Bowel Disease Poster Presentation at the Annual Crohn’s & Colitis Foundation Congress
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...
Clinical Trials Expand Patients' Treatment Options
For health conditions with no cure, effective treatments are the next best option. However, in order to make medical ...
infectiousdiseaseadvisor.com10d
Increased Fecal Calprotectin in Microscopic Colitis May Indicate More Severe Symptoms
Fecal calprotectin concentrations were increased in over a quarter of patients with symptomatic microscopic colitis and were linked to worse symptoms.
PharmiWeb4d
AbbVie’s SKYRIZI® (risankizumab) Accepted by the S…
Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative ColitisPRESS RELEASE – For UK consumer health, medical and trade media onlyRisankizumab will be ...